Clinical Trial

Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 10, 2024 (before its estimated February 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with CKD ( eGFR \< \<60 mL/min/1,73 m2) presenting to emergency department with isolated hyperkalemia will be study population. Pre and post treatment ECG and echocardiographic findings will be recorded. Investigator will not intervene with the treatment decision of responsible physician and will not delay any intervetion or treatment for the sake of study. Data will be compared in terms of ECHO and ECG findings depending on hyperkalemia level and response to treatment.
Trial Details
NCT Number NCT06635590
Lead Sponsor Saglik Bilimleri Universitesi
Conditions Chronic Kidney Disease (CKD), Hyperkalemia, Hemodialysis
Enrollment 40 participants
Start Date 2024-02-01
Primary Completion 2025-02-01 (estimated)
Study Completion 2025-02-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-10